12/2
03:41 pm
ecor
electroCore (NASDAQ:ECOR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
electroCore (NASDAQ:ECOR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/2
08:00 am
ecor
TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen
Low
Report
TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen
11/10
04:05 pm
ecor
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Low
Report
electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
11/5
04:05 pm
ecor
electroCore Announces Third Quarter 2025 Financial Results
High
Report
electroCore Announces Third Quarter 2025 Financial Results
10/24
12:21 pm
ecor
electroCore (NASDAQ:ECOR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
electroCore (NASDAQ:ECOR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/23
08:11 am
ecor
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025
Low
Report
electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025
10/8
12:20 pm
ecor
electroCore (NASDAQ:ECOR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
electroCore (NASDAQ:ECOR) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
10/3
04:05 pm
ecor
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Neutral
Report
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
9/30
08:00 am
ecor
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
Low
Report
gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms
9/29
08:00 am
ecor
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
Low
Report
electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium
9/24
10:15 am
ecor
Digital Migraine Treatment Devices Market to Reach USD 298.71 Million by 2030, Fueled by Non-Invasive Neuromodulation and Expanding Clinical Adoption | DataM Intelligence [Yahoo! Finance]
Low
Report
Digital Migraine Treatment Devices Market to Reach USD 298.71 Million by 2030, Fueled by Non-Invasive Neuromodulation and Expanding Clinical Adoption | DataM Intelligence [Yahoo! Finance]
9/22
08:00 am
ecor
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
Medium
Report
electroCore’s Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire’s 2025 Sleep Awards
9/10
04:05 pm
ecor
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Low
Report
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)